Nanjing RegeneCore Biotech Co.,Lt←‌d is established in the Biomedical V <§‍alley of National Nanjσαing Jiangbei New Area, with a research and oσ¥÷ffice base of nearly 4000 square♣₽ meters. It is one of the first research   and development institutions in the fiel↔β​<d of nanobodies in'π↓ China. The company's international scientific ×✔'consulting expert team has rich experi$ ence in the research and developm§Ω¶♦ent of cell therapy products and ≈δ✘clinical applications, proviπ∞ ding strong guarantees for the preσ'αcise positioning and sucπ•×♥cess rate of research and development products. T✘λ≤he company has mature and leading nanobodδπ↔πy screening technology, and cond∑≥ucts in-depth develop☆₹ment in multiple application fields ★↓←'based on this technology.